Literature DB >> 16331784

Concomitant therapy: an outcome variable for musculoskeletal disorders? Part 2: total joint replacement in osteoarthritis trials.

Jean-Francis Maillefert1, Gillian A Hawker, Laure Gossec, Nizar N Mahomed, Stefan Lohmander, Paul A Dieppe, Gustavo Zanoli, Marc C Hochberg, Maxime Dougados.   

Abstract

Interest has grown in using the requirement of total joint replacement (TJR) as a "hard" outcome measure. Limitations exist, however, in the use of such an outcome, in particular the variability in the decision to perform surgery, length of surgical waiting lists, and sensitivity to change. This special interest group is exploring ways of retaining the clinical relevance of TJR but overcoming the problems--2 alternative outcomes are being considered: "time to physician's decision to recommend surgery" and "time to fulfilling criteria for total joint replacement."

Entities:  

Mesh:

Year:  2005        PMID: 16331784

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis.

Authors:  P Ornetti; K Brandt; M-P Hellio-Le Graverand; M Hochberg; D J Hunter; M Kloppenburg; N Lane; J-F Maillefert; S A Mazzuca; T Spector; G Utard-Wlerick; E Vignon; M Dougados
Journal:  Osteoarthritis Cartilage       Date:  2009-02-09       Impact factor: 6.576

2.  The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement.

Authors:  L Gossec; S Paternotte; J F Maillefert; C Combescure; P G Conaghan; A M Davis; K-P Gunther; G Hawker; M Hochberg; J N Katz; M Kloppenburg; K Lim; L S Lohmander; N N Mahomed; L March; K Pavelka; L Punzi; E M Roos; L Sanchez-Riera; J A Singh; M E Suarez-Almazor; M Dougados
Journal:  Osteoarthritis Cartilage       Date:  2010-10-31       Impact factor: 6.576

3.  OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group.

Authors:  Laure Gossec; Simon Paternotte; Clifton O Bingham; Daniel O Clegg; Philippe Coste; Philip G Conaghan; Aileen M Davis; Giampaolo Giacovelli; Klaus-Peter Gunther; Gillian Hawker; Marc C Hochberg; Joanne M Jordan; Jeffrey N Katz; Margreet Kloppenburg; Arturo Lanzarotti; Keith Lim; L Stefan Lohmander; Nizar N Mahomed; Jean Francis Maillefert; Rebecca L Manno; Lyn M March; Steven A Mazzuca; Karel Pavelka; Leonardo Punzi; Ewa M Roos; Lucio C Rovati; Helen Shi; Jasvinder A Singh; Maria E Suarez-Almazor; Eleonora Tajana-Messi; Maxime Dougados
Journal:  J Rheumatol       Date:  2011-08       Impact factor: 4.666

4.  Disability for daily living is a predictor for joint replacement in patients with end-stage knee osteoarthritis.

Authors:  Lizu Liu; Muneaki Ishijima; Haruka Kaneko; Ippei Futami; Ryo Sadatsuki; Shinnosuke Hada; Anwarjan Yusup; Yukio Shimura; Mitsuaki Kubota; Yoshitomo Saita; Yuji Takazawa; Hiroshi Ikeda; Hisashi Kurosawa; Kazuo Kaneko
Journal:  J Bone Miner Metab       Date:  2013-08-07       Impact factor: 2.626

5.  OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials.

Authors:  R L Manno; C O Bingham; S Paternotte; L Gossec; H Halhol; G Giacovelli; L Rovati; S A Mazzuca; D O Clegg; H Shi; E Tajana Messi; A Lanzarotti; M Dougados
Journal:  Osteoarthritis Cartilage       Date:  2011-11-28       Impact factor: 6.576

6.  Exercise therapy may postpone total hip replacement surgery in patients with hip osteoarthritis: a long-term follow-up of a randomised trial.

Authors:  Ida Svege; Lars Nordsletten; Linda Fernandes; May Arna Risberg
Journal:  Ann Rheum Dis       Date:  2013-11-19       Impact factor: 19.103

7.  Development of a Tool to Predict Outcome of Autologous Chondrocyte Implantation.

Authors:  M Naomi Dugard; Jan Herman Kuiper; Jane Parker; Sally Roberts; Eric Robinson; Paul Harrison; James B Richardson
Journal:  Cartilage       Date:  2016-07-08       Impact factor: 4.634

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.